Omniscan (Gadodiamide)

Omniscan is a gadolinium‑based contrast agent used in magnetic resonance imaging to highlight anatomical details.

• Central nervous system imaging: improves lesion detection and delineation in the brain and spinal cord.
• Vascular imaging: enhances visualization of arteries, veins and vascular malformations.
• Body imaging: increases contrast of abdominal and pelvic organs for better lesion characterization.

• Gadodiamide is a gadolinium‑based chelate that shortens the T1 relaxation time of nearby water protons during MRI. By altering local magnetic properties, it increases signal intensity on T1‑weighted images, allowing clearer differentiation of vascular and tissue structures without interacting with specific cellular receptors.

Adverse reactions to Omniscan are generally mild but can vary in severity.

Common Side Effects

• Nausea: mild, transient feeling of stomach upset.
• Headache: mild to moderate discomfort.
• Injection site discomfort: pain or burning at the infusion site.
• Warm sensation: brief feeling of warmth or flushing.
• Dizziness: light‑headed feeling shortly after administration.

Serious or Rare Side Effects

• Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment.
• Anaphylactoid reaction: severe allergic response requiring immediate medical attention.
• Severe hypotension: sudden drop in blood pressure.
• Cardiac arrest: rare but life‑threatening event.
• Pulmonary edema: fluid accumulation in the lungs.
• Acute kidney injury: rapid decline in renal function.

Omniscan should be used with careful assessment of patient risk factors and under professional supervision.

• Renal function assessment: evaluate glomerular filtration rate before administration.
• History of allergic reactions: review prior contrast media reactions.
• Pregnancy: avoid unless clearly needed, as safety data are limited.
• Breastfeeding: consider discontinuation during treatment.
• Concomitant nephrotoxic drugs: use with caution.
• Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Omniscan may interact with other agents that affect renal function or hypersensitivity risk.

Major Interactions (Avoid)

• High‑dose intravenous iodinated contrast: increases risk of renal toxicity.
• Nephrotoxic antibiotics (e.g., aminoglycosides): may compound kidney injury.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may alter fluid balance and affect renal clearance.
• ACE inhibitors or ARBs: monitor renal function closely when combined.
• NSAIDs: can reduce renal perfusion, increasing risk of nephrotoxicity.
• Calcium channel blockers: may influence vascular response during injection.